CRISIL Limited
Financial trend (100/100) does the heavy lifting; valuation (10/100) is the drag.
ExpensiveOvervaluedStocksWizard rates CRISIL Limited a Hold, scoring 45/100 on our blended model. On 35.6x trailing earnings it sits pricier than the Financial Services median of about 24.3x. The price is about 6% below its 52-week high of ₹5,010.62 and 27% above the low of ₹3,689.72. Financial health scores 83/100, with a Piotroski F-score of 2/9. The average analyst target of ₹4,908 implies about 4% upside across 2 analysts. It clears 7 of 11 investability checks, with durability 91, valuation 19 and momentum 65 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹2,043.05.
Analyst views
1-year price
EOD · 2026-09-1252-week range
-6.24% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold45Piotroski F-score 2/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- No data: ROE above 15%
- Pass: Low debt (D/E < 0.5): 0.10x
- Pass: Positive free cash flow
- Pass: Revenue growth > 10%: 30%
- Pass: Earnings growing: 46%
- Pass: Net margin ≥ 10%: 21.6%
- No data: Current ratio > 1.5
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- Fail: Positive 1-year return
- No data: Altman Z in safe zone
- Fail: Piotroski ≥ 7: 2/9
Quarterly results
Annual financials
Shareholding
- Promoter71.9%
- Institutions15.9%
- Public & other12.3%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Healthy profit margin (21.6%).
Opportunities
- Earnings growing (46% YoY).
- Revenue growing (30% YoY).
Bear case
Weaknesses
- Weak Piotroski score (2/9).
Threats
- Rich valuation versus sector peers.
- Trades ~46% above our estimated fair value.
About CRISIL Limited
CRISIL Limited provides credit ratings, research, and risk and policy consulting services across India, Europe, North America, and international markets. Its Rating Services segment offers credit ratings for corporates, banks, and bank loans, along with credit analysis and grading services. The company also operates a Research, Analytics and Solutions segment providing analytical services.
CRISIL Limited — frequently asked questions
Is CRISIL Limited a buy, hold or sell?
StocksWizard currently rates CRISIL Limited (CRISIL) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is CRISIL Limited's fair value?
Our blended DCF and relative-valuation model estimates CRISIL Limited's fair value at about ₹2,553.81, versus a current price of ₹4,697.9 — roughly 46% downside. On that basis the stock looks overvalued by 46%.
Is CRISIL Limited financially healthy?
CRISIL Limited scores 83/100 on our financial-health model, with a Piotroski F-score of 2/9.
How has CRISIL Limited's share price performed?
CRISIL Limited is down 5% over the past year and up 17% over three months, and last traded at ₹4,697.9. Past performance doesn't predict future returns.
More in Financial Services
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.